MSF International President Dr Javid Abdelmoneim explains the difficulties he encountered in his previous work in treating sleeping sickness, a neglected tropical disease. The disease, almost always fatal without treatment, was previously treated using arsenic-derived drugs so toxic they killed patients. Our partner organisation, DNDi, has recently had approval for a ground-breaking new drug, acoziborole, which can cure sleeping sickness with one dose.